BRIEF published on 09/10/2024 at 01:15, 1 year 7 months ago XS Financial annonce l'approbation de l'arrangement par les porteurs de titres Acquisition Arrangement XS Financière Financement Du Cannabis Approbation Des Porteurs De Titres
BRIEF published on 09/10/2024 at 01:05, 1 year 7 months ago Cibolo Energy Partners Announces Final Closing on $279 Million Cibolo Energy Partners II, L.P. Growth Capital Cibolo Energy Partners $279 Million Fund Upstream And Midstream Private Debt Firm
BRIEF published on 09/10/2024 at 01:05, 1 year 7 months ago Cibolo Energy Partners annonce la clôture définitive de 279 millions de dollars pour Cibolo Energy Partners II, LP Capital De Croissance Partenaires Énergétiques De Cibolo Fonds De 279 Millions De Dollars En Amont Et Au Milieu Du Parcours Société De Dette Privée
BRIEF published on 09/10/2024 at 00:05, 1 year 7 months ago KBC Group Launches Capped Cash Tender Offer and Plans New Issuance of AT1 Securities Market Conditions Tender Offer Financial Strategy KBC Group AT1 Securities
BRIEF published on 09/10/2024 at 00:05, 1 year 7 months ago KBC Groupe lance une offre publique d'achat plafonnée et prévoit une nouvelle émission de titres AT1 Offre Publique D'achat Stratégie Financière Groupe KBC Conditions Du Marché Valeurs Mobilières AT1
BRIEF published on 09/09/2024 at 23:01, 1 year 7 months ago Déclaration de Marc de Garidel sur le Rapport Financier Semestriel 2024 d'Abivax Abivax Transparence IFRS Rapport Financier Patrimoine
BRIEF published on 09/09/2024 at 23:01, 1 year 7 months ago Statement by Marc de Garidel on Abivax's 2024 Half-Year Financial Report Financial Report Abivax Transparency IFRS Heritage
BRIEF published on 09/09/2024 at 22:40, 1 year 7 months ago ABIVAX présente ses résultats semestriels 2024 Résultats Semestriels Abivax Cybersécurité Contrôle Interne Défaillances
BRIEF published on 09/09/2024 at 22:40, 1 year 7 months ago ABIVAX presents its 2024 half-year results Cybersecurity Abivax Half-year Results Internal Control Failures
BRIEF published on 09/09/2024 at 22:35, 1 year 7 months ago BioNxt Receives Positive International Examination Report From the European Patent Office Multiple Sclerosis BioNxt Solutions European Patent Office Sublingual Drug Delivery Myasthenia Gravis
Published on 04/24/2026 at 00:25, 7 hours 36 minutes ago Golden Lake Announces Closing Date of April 30, 2026 for Arrangement with McEwen Inc.
Published on 04/24/2026 at 00:15, 7 hours 46 minutes ago Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call
Published on 04/24/2026 at 00:00, 8 hours 1 minute ago Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies
Published on 04/24/2026 at 00:00, 8 hours 1 minute ago Redwood AI Announces Chemical Pricing and Availability System Update to Its AI-Powered Platform, Supported by Government of Canada Innovation Funding
Published on 04/24/2026 at 07:40, 21 minutes ago AFYREN receives €3 million grant from the Grand Est Region through the European Just Transition Fund
Published on 04/24/2026 at 07:00, 1 hour 1 minute ago INFICON reports strong first quarter and raises guidance
Published on 04/24/2026 at 07:00, 1 hour 1 minute ago EQS-Adhoc: BB Biotech AG publishes its interim report
Published on 04/24/2026 at 07:00, 1 hour 1 minute ago BB Biotech Q1 2026: Share price outperformance, narrowing discount and active portfolio repositioning
Published on 04/23/2026 at 19:27, 12 hours 34 minutes ago NRJ Group - AGM 19 mai 2026 - Mise à disposition des documents préparatoires
Published on 04/23/2026 at 19:27, 12 hours 34 minutes ago Annual Shareholders' Meeting 2026 - Conditions of availability of the preparatory documents
Published on 04/23/2026 at 18:18, 13 hours 43 minutes ago Aéroports de Paris SA - Cession par le Groupe ADP à GMR Group de titres représentant 3,4% du capital de GAL, avec une option de cession portant sur 3,9% supplémentaires
Published on 04/23/2026 at 18:18, 13 hours 43 minutes ago Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
Published on 04/23/2026 at 18:09, 13 hours 52 minutes ago Emova Group - Résultats semestriels S1 2025/26
